Barclays’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Sell |
3,017
-17,322
| -85% | -$23K | ﹤0.01% | 4236 |
|
|
2025
Q1 | $66K | Sell |
20,339
-9,620
| -32% | -$31.2K | ﹤0.01% | 3818 |
|
|
2024
Q4 | $123K | Buy |
29,959
+22,941
| +327% | +$94.2K | ﹤0.01% | 3743 |
|
|
2024
Q3 | $45K | Buy |
7,018
+5,367
| +325% | +$34.4K | ﹤0.01% | 3939 |
|
|
2024
Q2 | $8K | Buy |
+1,651
| New | +$8K | ﹤0.01% | 4005 |
|